ReviewThe Journal of membrane biology2025
Stomatin and Stomatin-Like Proteins Can Regulate Transporter Proteins Activity and Has a Role in Cancer Metastasis.
Review in The Journal of membrane biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stomatin, encoded by STOM gene, is an integral membrane protein found in a wide variety of species. Although years have passed since the identification of stomatin, little has been known about the functional insights of stomatin among which stomatin undergoing homo-oligomerization, post and reverse-post modifications are the notable ones. Stomatin downregulation or overexpression is directly connected to its ability to control neutrophil degranulation, modulate activities of transporter proteins, and mediate cancer metastasis. Stomatin shares about 40-80% sequence similarity at its signature SPFH (stomatin, prohibitin, flotillin and Hlfk) domain region with the stomatin-like proteins (SLPs). Although stomatin and SLPs are reported to have various therapeutic activities, still gaps are there regarding their plausible mechanistic insights. Therefore, in future, studies should be aimed toward investigating the possible mechanistic pathways controlled by stomatin and SLPs which can be employed to understand the basis of many therapeutic targets. This review briefs about the different functions of stomatin focusing mainly on the transporter proteins and carcinogenicity modulation by stomatin and SLPs.
Indexed as
Identifiers
40637896What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.